| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of
*
Immunology and
Infectious Diseases, Wright-Fleming Institute, Imperial College, Norfolk Place London United Kingdom; and
Johns Hopkins Medical Institute Microarray Core, Broadway Research Building, Johns Hopkins University, 733 North Broadway, Baltimore, MD 21205
The proviral load in human T cell lymphotropic virus type 1 (HTLV-1) infection is typically constant in each infected host, but varies by >1000-fold between hosts and is strongly correlated with the risk of HTLV-1-associated inflammatory disease. However, the factors that determine an individual’s HTLV-1 proviral load remain uncertain. Experimental evidence from studies of host genetics, viral genetics, and lymphocyte function and theoretical considerations suggest that a major determinant of the equilibrium proviral load is the CD8+ T cell response to HTLV-1. In this study, we tested the hypothesis that the gene expression profile in circulating CD8+ and CD4+ lymphocytes distinguishes between individuals with a low proviral load of HTLV-1 and those with a high proviral load. We show that circulating CD8+ lymphocytes from individuals with a low HTLV-1 proviral load overexpressed a core group of nine genes with strong functional coherence: eight of the nine genes encode granzymes or other proteins involved in cell-mediated lysis or Ag recognition. We conclude that successful suppression of the HTLV-1 proviral load is associated with strong cytotoxic CD8+ lymphocyte activity in the peripheral blood.
This article has been cited by other articles:
|
|
 |
|
  S. L. Manuel, T. D. Schell, E. Acheampong, S. Rahman, Z. K. Khan, and P. Jain Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease J. Leukoc. Biol., November 1, 2009; 86(5): 1205 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kattan, A. MacNamara, A. G. Rowan, H. Nose, A. J. Mosley, Y. Tanaka, G. P. Taylor, B. Asquith, and C. R. M. Bangham The Avidity and Lytic Efficiency of the CTL Response to HTLV-1 J. Immunol., May 1, 2009; 182(9): 5723 - 5729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Sabouri, K. Usuku, D. Hayashi, S. Izumo, Y. Ohara, M. Osame, and M. Saito Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease Blood, September 15, 2008; 112(6): 2411 - 2420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Enose-Akahata, U. Oh, C. Grant, and S. Jacobson Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease Blood, September 15, 2008; 112(6): 2400 - 2410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Toulza, A. Heaps, Y. Tanaka, G. P. Taylor, and C. R. M. Bangham High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response Blood, May 15, 2008; 111(10): 5047 - 5053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Voisset, R. A. Weiss, and D. J. Griffiths Human RNA "Rumor" Viruses: the Search for Novel Human Retroviruses in Chronic Disease Microbiol. Mol. Biol. Rev., March 1, 2008; 72(1): 157 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Asquith, Y. Zhang, A. J. Mosley, C. M. de Lara, D. L. Wallace, A. Worth, L. Kaftantzi, K. Meekings, G. E. Griffin, Y. Tanaka, et al. In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection PNAS, May 8, 2007; 104(19): 8035 - 8040. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Komori, A. Hasegawa, K. Kurihara, T. Honda, H. Yokozeki, T. Masuda, and M. Kannagi Reduction of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Loads in Rats Orally Infected with HTLV-1 by Reimmunization with HTLV-1-Infected Cells. J. Virol., August 1, 2006; 80(15): 7375 - 7381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Asquith, A. J. Mosley, A. Barfield, S. E. F. Marshall, A. Heaps, P. Goon, E. Hanon, Y. Tanaka, G. P. Taylor, and C. R. M. Bangham A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load J. Gen. Virol., May 1, 2005; 86(5): 1515 - 1523. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
